Seedetrakti ja ainevahetust mõjutavad ravimid
Contracts total
396 925 €
Bids
3
Type
Supplies
Published
16.02.2024
Tender description
Käesoleva hanke eesmärk on sõlmida raamleping seedetrakti ja ainevahetust mõjutavate ravimite ostmiseks HD Lisas 1 toodud nimetuste ja kirjelduste alusel.
Awarded contracts
16.02.2024| Lot | Tenderer | Amount | Bids | Awarded |
|---|---|---|---|---|
| A01AB04 Amfoteritsiin B * | TAMRO EESTI OÜ | 18 726 € | 1 | 06.12.2023 |
| A02BC01 Omeprasool | MAGNUM MEDICAL OÜ framework agreement | 985 € | 3 | 06.12.2023 |
| A02BC01 Omeprasool | MAGNUM MEDICAL OÜ framework agreement | 14 180 € | 3 | 06.12.2023 |
| A02BC05 Esomeprasool | MAGNUM MEDICAL OÜ framework agreement | 7621 € | 2 | 06.12.2023 |
| A02BC05 Esomeprasool | MAGNUM MEDICAL OÜ framework agreement | 161 571 € | 2 | 06.12.2023 |
| A02BC02 Pantoprazool | MAGNUM MEDICAL OÜ framework agreement | 731 € | 3 | 06.12.2023 |
| A02BC02 Pantoprazool | MAGNUM MEDICAL OÜ framework agreement | 2730 € | 3 | 06.12.2023 |
| A02BC02 Pantoprazool | MAGNUM MEDICAL OÜ framework agreement | 970 € | 2 | 06.12.2023 |
| A02BC02 Pantoprazool | MAGNUM MEDICAL OÜ framework agreement | 2715 € | 2 | 06.12.2023 |
| A03AD02 Drotaverin | TAMRO EESTI OÜ framework agreement | 705 € | 3 | 08.12.2023 |
| A03AD02 Drotaverin | TAMRO EESTI OÜ framework agreement | 10 075 € | 3 | 06.12.2023 |
| A03AD02 Drotaverin | TAMRO EESTI OÜ framework agreement | 930 € | 3 | 08.12.2023 |
| A03AD02 Drotaverin | TAMRO EESTI OÜ framework agreement | 6198 € | 3 | 06.12.2023 |
| A06AD15 Makrogool | MAGNUM MEDICAL OÜ framework agreement | 189 € | 2 | 06.12.2023 |
| A06AD15 Makrogool | MAGNUM MEDICAL OÜ framework agreement | 2527 € | 2 | 06.12.2023 |
| A06AD85 Naatriumsulf.+magneesiumsulf.heptahüdraat+ kaaliumsulf. | TAMRO EESTI OÜ framework agreement | 337 € | 2 | 08.12.2023 |
| A06AD85 Naatriumsulf.+magneesiumsulf.heptahüdraat+ kaaliumsulf. | TAMRO EESTI OÜ framework agreement | 22 490 € | 2 | 06.12.2023 |
| A06AG11 Na.laurilüülsulfoatsetaat+ Na citr.+ sorbitool | MAGNUM MEDICAL OÜ framework agreement | 1244 € | 2 | 06.12.2023 |
| A06AG11 Na.laurilüülsulfoatsetaat+ Na citr.+ sorbitool | MAGNUM MEDICAL OÜ framework agreement | 27 986 € | 2 | 06.12.2023 |
| A07BA01 Aktiivsüsi | osaühing KALVERTON framework agreement | 585 € | 3 | 30.01.2024 |
| A07BA01 Aktiivsüsi | osaühing KALVERTON framework agreement | 8775 € | 3 | 21.12.2023 |
| A07EA06 Budenosid* | TAMRO EESTI OÜ | 13 453 € | 1 | 06.12.2023 |
| A09AA02 Lipaas+amülaas+proteaas | MAGNUM MEDICAL OÜ | 9142 € | 2 | 06.12.2023 |
| A10AB05 Insuliin aspart. lühikese toimeajaga | MAGNUM MEDICAL OÜ framework agreement | 2361 € | 2 | 06.12.2023 |
| A10AB05 Insuliin aspart. lühikese toimeajaga | MAGNUM MEDICAL OÜ framework agreement | 18 886 € | 2 | 06.12.2023 |
| A10BH05 Linagliptin | TAMRO EESTI OÜ framework agreement | 3630 € | 2 | 08.12.2023 |
| A10BH05 Linagliptin | TAMRO EESTI OÜ framework agreement | 14 518 € | 2 | 06.12.2023 |
| A10BK03 Empagliflosiin | TAMRO EESTI OÜ | 23 969 € | 2 | 06.12.2023 |
| A11CC05 Vitamiin D3 (colecalciferol) | TAMRO EESTI OÜ framework agreement | 96 € | 1 | 08.12.2023 |
| A11CC05 Vitamiin D3 (colecalciferol) | TAMRO EESTI OÜ framework agreement | 28 665 € | 1 | 06.12.2023 |
| A12CC04 Magnesium citrat | MAGNUM MEDICAL OÜ framework agreement | 369 € | 2 | 06.12.2023 |
| A12CC04 Magnesium citrat | MAGNUM MEDICAL OÜ framework agreement | 10 319 € | 2 | 06.12.2023 |
In a framework agreement with several suppliers, the amount is the framework's maximum volume, not each supplier's actual orders.
Tender lots
26| Lot | Estimated value | Deadline |
|---|---|---|
| A01AB09 Mükonasool | ||
| A01AB04 Amfoteritsiin B * | ||
| A02BC01 Omeprasool | ||
| A02BC05 Esomeprasool | ||
| A02BC02 Pantoprazool | ||
| A02BC02 Pantoprazool | ||
| A03AD02 Drotaverin | ||
| A03AD02 Drotaverin | ||
| A03AX13 Simetikoon | ||
| A03AX13 Simetikoon | ||
| A06AD11 Laktuloos | ||
| A06AD15 Makrogool | ||
| A06AD85 Naatriumsulf.+magneesiumsulf.heptahüdraat+ kaaliumsulf. | ||
| A06AH03 Naloxegool | ||
| A06AG11 Na.laurilüülsulfoatsetaat+ Na citr.+ sorbitool | ||
| A07BA01 Aktiivsüsi | ||
| A07EA06 Budenosid* | ||
| A09AA02 Lipaas+amülaas+proteaas | ||
| A10AB01 Humaaninsuliin, lühikese toimeajaga | ||
| A10AB05 Insuliin aspart. lühikese toimeajaga | ||
| A10BH05 Linagliptin | ||
| A10BK03 Empagliflosiin | ||
| A11CC05 Vitamiin D3 (colecalciferol) | ||
| A12AX80 Calcium+colecalciferol | ||
| A12CC04 Magnesium citrat | ||
| A16AA05 Kargluumhape |
Similar open tenders
- Parenteraalsed toitelahusedOpen for bidsDeadline 20.10.2026 2 daysEstimated value 400 000 €Published 18.09.2026
- KlesrovimabOpen for bidsDeadline 20.10.2026 2 daysEstimated value 190 000 €Published 05.10.2026
- Puhasruumide desinfektsiooni- ja puhastusvahendidOpen for bidsDeadline 21.10.2026 3 daysPublished 17.09.2026
- Urogenitaalsüsteemi ravimid ja hormoonravimidOpen for bidsDeadline 23.10.2026 4 daysPublished 18.09.2026
- Ravim B01AB05 EnoksapariinOpen for bidsDeadline 27.10.2026 9 daysPublished 21.09.2026
- Kemoteraapias kasutatavad ravimidOpen for bidsDeadline 27.10.2026 9 daysPublished 22.09.2026
Source: Public Procurement Register open data. Amounts exclude VAT. The notice published in the Public Procurement Register is binding.